Zhejiang Hisoar Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002099.SZ

Zhejiang Hisoar Pharmaceutical Co., Ltd. Net Income Margin for the year ending December 31, 2023: -19.34%

Zhejiang Hisoar Pharmaceutical Co., Ltd. Net Income Margin is -19.34% for the year ending December 31, 2023, a -694.22% change year over year. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.

Zhejiang Hisoar Pharmaceutical Co., Ltd. Net Income Margin for the year ending December 31, 2022 was 3.25%, a -15.07% change year over year.
Zhejiang Hisoar Pharmaceutical Co., Ltd. Net Income Margin for the year ending December 31, 2021 was 3.83%, a -70.38% change year over year.
Zhejiang Hisoar Pharmaceutical Co., Ltd. Net Income Margin for the year ending December 31, 2020 was 12.94%, a -50.63% change year over year.
Zhejiang Hisoar Pharmaceutical Co., Ltd. Net Income Margin for the year ending December 31, 2019 was 26.20%, a 17.75% change year over year.

Key data

Date	Net Income Margin	EBITDA Margin	EBIT Margin	EBITDA

Shenzhen Stock Exchange: 002099.SZ

Zhejiang Hisoar Pharmaceutical Co., Ltd.

CEO	Mr. Guorui Xu
IPO Date	Dec. 26, 2006
Location	China
Headquarters	No. 100, Waisha Branch Road
Employees	2,612
Sector	Healthcare
Industries Pharmaceuticals Chemicals & Advanced Materials Cleaning Supplies Drugstores & Retail Pharmacies Personal Care Petrochemicals Plastics Tobacco

Description

Zhejiang Hisoar Pharmaceutical Co., Ltd., a pharmaceutical company, produces and sells fine chemicals and special raw drugs in China and internationally. It offers antibiotic, anti-virus, cardiovascular, sugar-reducing, and other materials; and medicine intermediates, and other customized and processed products, such as clindamycin, 4-AA Iso-carbapenem series, thiamphenicol, florfenicol, voglibose, eclindamycin, 4-AA iso-carbapenem, thiamphenicol, florfenicol, voglibose, etc. It also exports its products. The company was founded in 1966 and is based in Taizhou, China.

Key trends

Past 5 years